{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:47:35Z","timestamp":1792144055504,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system with prominent neurodegenerative components. The triggering and progression of MS is associated with transcriptional and epigenetic alterations in several tissues, including peripheral blood. The combined influence of transcriptional and epigenetic changes associated with MS has not been assessed in the same individuals. Here we generated paired transcriptomic (RNA-seq) and DNA methylation (Illumina 450\u2009K array) profiles of CD4+ and CD8+ T cells (CD4, CD8), using clinically accessible blood from healthy donors and MS patients in the initial relapsing-remitting and subsequent secondary-progressive stage. By integrating the output of a differential expression test with a permutation-based non-parametric combination methodology, we identified 149 differentially expressed (DE)\u00a0genes in both CD4 and CD8 cells collected from MS patients. Moreover, by leveraging the methylation-dependent regulation of gene expression, we identified the gene <jats:italic>SH3YL1<\/jats:italic>, which displayed significant correlated expression and methylation changes in MS patients. Importantly, silencing of <jats:italic>SH3YL1<\/jats:italic> in primary human CD4 cells demonstrated its influence on T cell activation. Collectively, our strategy based on paired sampling of several cell-types provides a novel approach to increase sensitivity for identifying shared mechanisms altered in CD4 and CD8 cells of relevance in MS in small sized clinical materials.<\/jats:p>","DOI":"10.1038\/s41598-019-48493-7","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T10:03:05Z","timestamp":1566208985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0896","authenticated-orcid":false,"given":"Sunjay Jude","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ruhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubin Narayan","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Lagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestoras","family":"Karathanasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-1444","authenticated-orcid":false,"given":"Mohsen","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Planell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-3012","authenticated-orcid":false,"given":"Angelika","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-959X","authenticated-orcid":false,"given":"Ioannis","family":"Tsamardinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8329-5219","authenticated-orcid":false,"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Jagodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Tegn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gomez-Cabrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"48493_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet (London, England) 372, 1502\u201317 (2008).","journal-title":"Lancet (London, England)"},{"key":"48493_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Prim. 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"48493_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ana.22609","volume":"70","author":"NA Patsopoulos","year":"2011","unstructured":"Patsopoulos, N. A. et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 70, 897\u2013912 (2011).","journal-title":"Ann. Neurol."},{"key":"48493_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"AH Beecham","year":"2013","unstructured":"Beecham, A. H. et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353\u201360 (2013).","journal-title":"Nat. Genet."},{"key":"48493_CR5","doi-asserted-by":"publisher","unstructured":"International Multiple Sclerosis Genetics Consortium. et al. The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility. bioRxiv 143933, https:\/\/doi.org\/10.1101\/143933 (2017).","DOI":"10.1101\/143933"},{"key":"48493_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219 (2011).","journal-title":"Nature"},{"key":"48493_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra, M. & Martin, R. Immunology of Multiple sclerosis. Annu. Rev. Immunol. 23, 683\u2013747 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"48493_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.4049\/jimmunol.165.3.1641","volume":"165","author":"CM Pelfrey","year":"2000","unstructured":"Pelfrey, C. M. et al. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 165, 1641\u201351 (2000).","journal-title":"J. Immunol."},{"key":"48493_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1474-4422(14)70041-9","volume":"13","author":"S Sawcer","year":"2014","unstructured":"Sawcer, S., Franklin, R. J. M. & Ban, M. Multiple sclerosis genetics. Lancet. Neurol. 13, 700\u20139 (2014).","journal-title":"Lancet. Neurol."},{"key":"48493_CR10","doi-asserted-by":"publisher","first-page":"287ra74","DOI":"10.1126\/scitranslmed.aaa8038","volume":"7","author":"Y Cao","year":"2015","unstructured":"Cao, Y. et al. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis. Sci. Transl. Med. 7, 287ra74\u2013287ra74 (2015).","journal-title":"Sci. Transl. Med."},{"key":"48493_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1034\/j.1399-0039.2000.550205.x","volume":"55","author":"A Fogdell-Hahn","year":"2000","unstructured":"Fogdell-Hahn, A., Ligers, A., Gr\u00f8nning, M., Hillert, J. & Olerup, O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55, 140\u20138 (2000).","journal-title":"Tissue Antigens"},{"key":"48493_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.192.3.393","volume":"192","author":"H Babbe","year":"2000","unstructured":"Babbe, H. et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393\u2013404 (2000).","journal-title":"J. Exp. Med."},{"key":"48493_CR13","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/hmg\/ddq090","volume":"19","author":"KS Gandhi","year":"2010","unstructured":"Gandhi, K. S. et al. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet. 19, 2134\u20132143 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"48493_CR14","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1177\/1352458513500553","volume":"19","author":"R Ratzer","year":"2013","unstructured":"Ratzer, R. et al. Gene expression analysis of relapsing\u2013remitting, primary progressive and secondary progressive multiple sclerosis. Mult. Scler. J. 19, 1841\u20131848 (2013).","journal-title":"Mult. Scler. J."},{"key":"48493_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0374-0","volume":"8","author":"D Gomez-Cabrero","year":"2016","unstructured":"Gomez-Cabrero, D. et al. High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis. Genome Med. 8, 124 (2016).","journal-title":"Genome Med."},{"key":"48493_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14788-w","volume":"7","author":"F Marabita","year":"2017","unstructured":"Marabita, F. et al. Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship. Sci. Rep. 7, 14589 (2017).","journal-title":"Sci. Rep."},{"key":"48493_CR17","doi-asserted-by":"publisher","unstructured":"Gomez-Cabrero, D. et al. Data integration in the era of omics: current and future challenges, https:\/\/doi.org\/10.1186\/1752-0509-8-S2-I1.","DOI":"10.1186\/1752-0509-8-S2-I1"},{"key":"48493_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ygeno.2007.11.005","volume":"91","author":"K Tan","year":"2008","unstructured":"Tan, K., Tegner, J. & Ravasi, T. Integrated approaches to uncovering transcription regulatory networks in mammalian cells. Genomics 91, 219\u2013231 (2008).","journal-title":"Genomics"},{"key":"48493_CR19","doi-asserted-by":"publisher","first-page":"29179","DOI":"10.3390\/ijms161226148","volume":"16","author":"M Hofmann-Apitius","year":"2015","unstructured":"Hofmann-Apitius, M. et al. Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders. Int. J. Mol. Sci. 16, 29179\u201329206 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"48493_CR20","doi-asserted-by":"crossref","unstructured":"Pesarin, F. & Salmaso, L. Permutation tests for complex data: theory, applications, and software. (Wiley, 2010).","DOI":"10.1002\/9780470689516"},{"key":"48493_CR21","doi-asserted-by":"publisher","first-page":"e0165545","DOI":"10.1371\/journal.pone.0165545","volume":"11","author":"N Karathanasis","year":"2016","unstructured":"Karathanasis, N. et al. omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data. PLoS One 11, e0165545 (2016).","journal-title":"PLoS One"},{"key":"48493_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.smim.2011.08.008","volume":"23","author":"L Wang","year":"2011","unstructured":"Wang, L., Xiong, Y. & Bosselut, R. Maintaining CD4-CD8 lineage integrity in T cells: where plasticity serves versatility. Semin. Immunol. 23, 360\u20137 (2011).","journal-title":"Semin. Immunol."},{"key":"48493_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson, T., Barcellos, L. F. & Alfredsson, L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13, 25\u201336 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"48493_CR24","first-page":"481","volume":"70","author":"F Pesarin","year":"2010","unstructured":"Pesarin, F. & Salmaso, L. The permutation testing approach: a review. Statistica 70, 481\u2013509 (2010).","journal-title":"Statistica"},{"key":"48493_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0621-5","volume":"16","author":"DR Zerbino","year":"2015","unstructured":"Zerbino, D. R., Wilder, S. P., Johnson, N., Juettemann, T. & Flicek, P. R. The ensembl regulatory build. Genome Biol. 16, 56 (2015).","journal-title":"Genome Biol."},{"key":"48493_CR26","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1128\/MCB.22.9.3157-3173.2002","volume":"22","author":"M Curradi","year":"2002","unstructured":"Curradi, M., Izzo, A., Badaracco, G. & Landsberger, N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol. 22, 3157\u201373 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"48493_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","volume":"15","author":"R Hohlfeld","year":"2016","unstructured":"Hohlfeld, R., Dornmair, K., Meinl, E. & Wekerle, H. The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets. Lancet Neurol 15, 198\u2013209 (2016).","journal-title":"Lancet Neurol"},{"key":"48493_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","volume":"110","author":"U Feger","year":"2007","unstructured":"Feger, U. et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110, 568\u2013577 (2007).","journal-title":"Blood"},{"key":"48493_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ana.21705","volume":"66","author":"Y-H Huang","year":"2009","unstructured":"Huang, Y.-H. et al. Specific central nervous system recruitment of HLA-G+ regulatory T cells in multiple sclerosis. Ann. Neurol. 66, 171\u2013183 (2009).","journal-title":"Ann. Neurol."},{"key":"48493_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12014-019-9241-5","volume":"16","author":"T Berge","year":"2019","unstructured":"Berge, T. et al. Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls. Clin. Proteomics 16, 19 (2019).","journal-title":"Clin. Proteomics"},{"key":"48493_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577\u2013589 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"48493_CR32","doi-asserted-by":"publisher","unstructured":"Barro, C. et al. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain, https:\/\/doi.org\/10.1093\/brain\/awy154 (2018).","DOI":"10.1093\/brain\/awy154"},{"key":"48493_CR33","doi-asserted-by":"crossref","unstructured":"Urbanek, A. N., Chan, R. & Ayscough, K. R. Function and interactions of the Ysc84\/SH3yl1 family of actin- and lipid-binding proteins. Biochem. Soc. Trans. 43 (2015).","DOI":"10.1042\/BST20140221"},{"key":"48493_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.cellsig.2014.01.027","volume":"26","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi, M., Harada, K., Negishi, M. & Katoh, H. Dock4 forms a complex with SH3YL1 and regulates cancer cell migration. Cell. Signal. 26, 1082\u20131088 (2014).","journal-title":"Cell. Signal."},{"key":"48493_CR35","doi-asserted-by":"crossref","unstructured":"Hasegawa, J. et al. SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositide-binding domain. J. Cell Biol. 193 (2011).","DOI":"10.1083\/jcb.201012161"},{"key":"48493_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross, S. H. & Cantrell, D. A. Signaling and Function of Interleukin-2 in T Lymphocytes. Annu. Rev. Immunol. 36, 411\u2013433 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"48493_CR37","unstructured":"Andrews, S. FastQC A Quality Control tool for High Throughput Sequence Data, http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"48493_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).","journal-title":"EMBnet.journal"},{"key":"48493_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"48493_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u20139 (2015).","journal-title":"Bioinformatics"},{"key":"48493_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/biostatistics\/kxr054","volume":"13","author":"KD Hansen","year":"2012","unstructured":"Hansen, K. D., Irizarry, R. A. & WU, Z. Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics 13, 204\u2013216 (2012).","journal-title":"Biostatistics"},{"key":"48493_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"48493_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"48493_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289\u2013300 (1995).","journal-title":"Series B (Methodological)"},{"key":"48493_CR45","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"48493_CR46","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris, T. J. et al. ChAMP: 450k Chip Analysis Methylation Pipeline. Bioinformatics 30, 428\u2013430 (2014).","journal-title":"Bioinformatics"},{"key":"48493_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189\u2013196 (2013).","journal-title":"Bioinformatics"},{"key":"48493_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1214\/12-AOAS597","volume":"7","author":"EF Lock","year":"2013","unstructured":"Lock, E. F., Hoadley, K. A., Marron, J. S. & Nobel, A. B. Joint and individual variation explained (JIVE) for integrated analysis of multiple data types. Ann. Appl. Stat. 7, 523\u2013542 (2013).","journal-title":"Ann. Appl. Stat."},{"key":"48493_CR49","doi-asserted-by":"publisher","unstructured":"Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis, https:\/\/doi.org\/10.1186\/1471-2105-10-161.","DOI":"10.1186\/1471-2105-10-161"},{"key":"48493_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"48493_CR51","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"48493_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245\u2013254 (2003).","journal-title":"Nat. Genet."},{"key":"48493_CR53","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2012.03.051","volume":"149","author":"W Deng","year":"2012","unstructured":"Deng, W. et al. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell 149, 1233\u201344 (2012).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48493-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:38:22Z","timestamp":1671280702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48493-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48493-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FP has received research grants from Biogen, Genzyme, Merck KGaA and Novartis, and fees for serving as Chair of DMC in clinical trials with Parexel. TO has received advisory board and\/or lecture honoraria, and\/or unrestricted MS research grants from Biogen, Novartis, Merck, Genzyme, Allmiral, AstraZeneca and Roche. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11996"}}